Hepatitis E: An old infection with new implications

Blood Transfusion

Volumn 13, Issue 1, 2015, Pages 6-20

  Marano, Giuseppe ^a   Vaglio, Stefania ^a,b   Pupella, Simonetta ^a   Facco, Giuseppina ^a,c   Bianchi, Maria ^a,d   Calizzani, Gabriele ^a   Candura, Fabio ^a   Catalano, Liviana ^a   Farina, Blandina ^a   Lanzoni, Monica ^a,e   Piccinini, Vanessa ^a   Liumbruno, Giancarlo M ^a   Grazzini, Giuliano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Azienda Ospedaliera Città della Salute e della Scienza   (Italy)

^d FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Blood donor; Hepatitis E virus; HEV genotype; HEV prevalence; Transfusion transmitted hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; DRINKING WATER; HEPATITIS E VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ABDOMINAL PAIN; ACUTE HEPATITIS; ALCOHOL CONSUMPTION; ANAPHYLACTOID PURPURA; ANTIBODY RESPONSE; ARTHRALGIA; ASTHENIA; AUTOIMMUNE HEPATITIS; BELL PALSY; BLOOD DONOR; BLOOD TRANSFUSION; BRACHIAL PLEXUS NEUROPATHY; CHRONIC HEPATITIS; CLINICAL FEATURE; ENZYME IMMUNOASSAY; FECES ANALYSIS; FEVER; FOOD CONTAMINATION; FOOD POISONING; FULMINANT HEPATIC FAILURE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GUILLAIN BARRE SYNDROME; HEMODIALYSIS PATIENT; HEMOLYSIS; HEMOPHILIA; HEPATITIS E; HUMAN; IMMUNE RESPONSE; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; IMMUNOGENICITY; INCIDENCE; JAUNDICE; LIVER INJURY; MALAISE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MENINGOENCEPHALITIS; MORPHOLOGY; NONHUMAN; OPEN READING FRAME; PANCREATITIS; POSTTRANSFUSION HEPATITIS; PREVALENCE; RASH; REVIEW; SCREENING TEST; SEROLOGY; SEROPREVALENCE; SEXUAL TRANSMISSION; TAXONOMY; THROMBOCYTOPENIA; TRANSFUSION MEDICINE; VACCINATION; VERTICAL TRANSMISSION; VIRAL CONTAMINATION; VIREMIA; VIRUS GENOME; VIRUS LOAD; VIRUS TRANSMISSION; VOMITING; WATER CONTAMINATION; ACUTE LIVER FAILURE; BLOOD; BLOOD COMPONENT THERAPY; COMMUNICABLE DISEASE; FEMALE; HEPATITIS E VIRUS; MALE; MORTALITY; PREGNANCY; PREGNANCY COMPLICATION; TRANSMISSION;

BLOOD COMPONENT TRANSFUSION; COMMUNICABLE DISEASES, EMERGING; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; LIVER FAILURE, ACUTE; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, VIRAL;

EID: 84922324451     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2014.0063-14     Document Type: Review

References (167)

1. Picker SM. Current methods for the reduction of blood-borne pathogens: a comprehensive literature review. Blood Transfus 2013;11:343-8.
2. Stramer SL, Dodd RY, for the AABB Transfusion-Transmitted Diseases Emerging Infectious Diseases Subgroup. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. Transfusion 2013;53:2375-83.
3. Liumbruno GM, Calteri D, Petropulacos K, et al. The Chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus 2008;6:199-210.
4. Grazzini G, Liumbruno GM, Pupella S, et al. West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system. Blood Transfus 2008;6:235-7.
5. Pupella S, Pisani G, Cristiano K, et al. West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safety. Blood Transfus 2013;11:563-74.
6. Romanò L, Paladini S, Tagliacarne C, et al. Hepatitis E in Italy: a long-term prospective study. J Hepatol 2011;54:34-40.
7. Arends JE, Ghisetti V, Irving W, et al. Hepatitis E: an emerging infection in high income countries. J Clin Virol 2014;59:81-8.
8. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980;68:818-23.
9. Wong DC, Purcell RH, Sreenivasan MA, et al. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis etiology. Lancet 1980;2:876-9.
10. Aggarwal R. Hepatitis E. Historical, contemporary and future perspectives. J Gastroenterol Hepatol 2011;26:72-82.
11. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012;379:2477-88.
12. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247:1335-9.
13. Tam AW, Smith MM, Guerra ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991;185:120-31.
14. Meng XJ, Anderson DA, Arankalle VA, et al. Hepeviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ, editors. Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy. San Diego, CA: Elsevier; 2011. p. 1021-8.
15. Smith DB, Johannessen I, Vanek J, et al. Evolution of the hepatitis E virus hypervariable region. J Gen Virol 2012;93:2408-18.
16. Cao D, Meng XJ. Molecular biology and replication of hepatitis E virus. Emerg Microbes Infect 2012;1:e17.
17. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006;16:5-36.
18. Smith DB, Purdy MA, Simmonds P. Genetic variability and the classification of hepatitis E virus. J Virol 2013;87:4161-9.
19. Pérez-Gracia MT, Mateos Lindemann ML, Caridad Montalvo Villalba M. Hepatitis E: current status. Rev Med Virol 2013;23:384-98.
20. Acharya SK, Panda SK. Hepatitis E: water, water everywhere - now a global disease. J Hepatol 2011;54:9-11.
21. Mizuo H, Yazaki Y, Sugawara K, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol 2005;76:341-9.
22. Dalton HR, Fellows HJ, Gane EJ, et al. Hepatitis E in New Zealand. J Gastroenterol Hepatol 2007;22:1236-40.
23. Zhang W, He Y, Wang H, et al. Hepatitis E virus genotype diversity in eastern China. Emerg Infect Dis 2010;16:1630-2.
24. Tsang TH, Denison EK, Williams HV, et al. Acute hepatitis E infection acquired in California. Clin Infect Dis 2000;30:618-9.
25. Kumar S, Subhadra S, Singh B, et al. Hepatitis E virus: the current scenario. Int J Infect Dis 2013;17:228-33.
26. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008;48:494-503.
27. Panda SK, Thakral D, Rehman, S. Hepatitis E virus. Rev Med Virol 2007;17:151-80.
28. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. Current concepts. N Engl J Med 2012;367:1237-44.
29. Mansuy JM, Legrand-Abravanel F, Calot JP, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008;80:289-93.
30. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309-12.
31. Pérez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: an emerging disease. Infect Genet Evol 2014;22C:40-59.
32. Nelson KE. Transmission of hepatitis E virus by transfusion: what is the risk? Transfusion 2014;54:8-10.
33. Yugo DM, Meng XJ. Hepatitis E virus: foodborne, waterborne and zoonotic Transmission. Int J Environ Res Public Health 2013;10:4507-33.
34. Pérez-Gracia MT, Mateos-Lindemann ML. Hepatitis E. Current perspectives. Medicine Clínica 2012;139:404-11.
35. Colson P, Borentain P, Queyriaux, B, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010;202:825-34.
36. Meng XJ. Zoonotic and foodborne transmission of hepatitis E virus. Semin Liver Dis 2013;33:41-9.
37. Echevarría JM. Light and darkness: prevalence of hepatitis E virus infection among the general population. Scientifica 2014;2014:481016.
38. Thomas HC, Lok ASF, Locarnini SA, Zuckerman AJ, editors. Viral Hepatitis. 4th ed. Wiley-Blackwell; 2013.
39. Aggarwal R, Naik SR. Hepatitis E: does person to person spread occur? Indian J Gastroenterol 1992;11:109-12.
40. Teshale EH, Grytdal SP, Howard C, et al. Evidence of person-toperson transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis 2010;50:1006-10.
41. Khuroo MS, Dar MY. Hepatitis E: evidence for person to person transmission and inability of low dose immunoglobulin from Indian source to prevent it. Ind J Gastroenterol 1992;11:113-6.
42. Toyoda H, Honda T, Hayashi K, et al. Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia. Intervirology 2008;51:21-5.
43. Hosseini-Moghaddam SM, Zarei A, Alavian SM, Mansouri M. Hepatitis E virus infection: a general review with a focus on hemodialysis and kidney transplant patients. Am J Nephrol 2010;31:398-407.
44. Khuroo MS, Kamili S. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepatitis 2009;16:519-23.
45. Psichogiou M, Tzala E, Boletis J, et al. Hepatitis E virus infection in individuals at high risk of transmission of non-A, non-B hepatitis and sexually transmitted diseases. Scand J Infect Dis 1996;28:443-5.
46. Hoerning A, Hegen B, Wingen AM, et al. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients - a single-center experience. Pediatr Transplant 2012;16:742-7.
47. Versluis J, Pas SD, Agteresch HJ, et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 2013;122:1079-86.
48. Waggoner JJ, Soda EA, Deresinski S. Rare and emerging viral infections in transplant recipients. Clin Infect Dis 2013;57:1182-8.
49. Arankalle VA, Chobe MS. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang 2000;79:72-4.
50. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusiontransmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004;44:934-40.
51. Matsubayashi K, Kang JH, Sakata H, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008;48:1368-75.
52. Matsubayashi K, Sakata H, Ikeda H. Hepatitis E virus infection and blood transfusion in Japan. ISBT Sci Ser 2011;6:344-9.
53. Tamura A, Shimizu YK, Tanaka T, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007;37:113-20.
54. Mitsui T, Tsukamoto Y, Yamazaki C, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 2004;74:563-72.
55. Boxall E, Herborn A, Kochethu G, et al. Transfusiontransmitted hepatitis E in a 'non-hyperendemic' country. Transfus Med 2006;16:79-83.
56. Colson P, Coze C, Gallian P, et al. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007;13:648-9.
57. Kumar N, Kumar Sarin S. Hepatitis E - Is it a risk to transfusion safety? Asian J Transfus Sci 2013;7:1-3.
58. Xu C, Wang RY, Schechterly CA, et al. An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients. Transfusion 2013;53:2505-11.
59. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004;19:778-84.
60. Tamura A, Shimizu YK, Tanaka T, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007;37:113-20.
61. Haïm-Boukobza S, Ferey MP, Vétillard AL, et al. Transfusion transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 2012;57:1374-8.
62. Kimura Y, Gotoh A, Katagiri S, et al. Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes. Blood Transfus 2014;12:103-6.
63. Baylis SA, Gärtner T, Nick S, et al. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012;103:89-90.
64. Dreier J, Juhl D. Autochthonous hepatitis E virus infections: a new transfusion-associated risk? Transfus Med Hemother 2014;41:29-39.
65. Kamar N, Dalton HR, Abravanel F, et al. Hepatitis E virus infection. Clin Microbiol Rev 2014;27:116-38.
66. Ijaz S, Szypulska R, Tettmar KI, et al. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang 2012;102:272.
67. Baylis SA, Koc Ö, Nick S, et al. Widespread distribution of hepatitis E virus in plasma fractionation pools. Vo x Sang 2012;102:182-3.
68. Mannucci PM, Gringeri A, Santagostino E, et al. Low risk of transmission of hepatitis E virus by large-pool coagulation factor concentrates. Lancet 1994;343:597-8.
69. Liumbruno GM, Sodini ML, Grazzini G. Tuscan Transfusion System. Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma. Blood Transfus 2008;6:25-36.
70. Arankalle VA, Chobe LP. Hepatitis E virus: can it be transmitted parenterally? J Viral Hepat 1999;6:161-4.
71. Barzilai A, Schulman S, Karetnyi YV, et al. Hepatitis E virus infection in hemophiliacs. J Med Virol 1995;46:153-6.
72. Andonov A, Rock G, Lin L, et al. Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma. Vox Sang 2014; doi: 10.1111/vox.12156.
73. Fukuda S, Sunaga J, Saito N, et al. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus. J Med Virol 2004;73:554-61.
74. Gajjar MD, Bhatnagar NM, Sonani RV, et al. Hepatitis E seroprevalence among blood donors: a pilot study from Western India. Asian J Transfus Sci 2014;8:29-31.
75. Dalton HR, Hunter JG, Bendall RP. Hepatitis E. Curr Opin Infect Dis 2013;26:471-8.
76. Nanda SK, Ansari IH, Acharya SK, et al. Protracted viremia during acute sporadic hepatitis E virus infection. Gastroenterology 1995;108:225-30.
77. Traoré KA, Rouamba H, Nébié Y, et al. Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso. PLoS One 2012;7:e48125.
78. Ibrahim EH, Abdelwahab SF, Nady S, et al. Prevalence of anti-HEV IgM among blood donors in Egypt. Egypt J Immunol 2011;18:47-58.
79. Abdel Hady SI, El-Din MS, El-Din ME. A high hepatitis E virus (HEV) seroprevalence among unpaid blood donors and haemodialysis patients in Egypt. J Egypt Public Health Assoc 1998;73:165-79.
80. Meldal BHM, Sarkodie F, Owusu-Ofori S, et al. Hepatitis E virus infection in Ghanaian blood donors - the importance of immunoassay selection and confirmation. Vo x Sang 2013;104:30-6.
81. Neffati H, Ritter J, Feki S, et al. Seroprevalence of hepatitis E virus infection in rural and urban populations, Tunisia. Clin Microbiol Infect 2012;18:E119-21.
82. Hannachi N, Boughammoura L, Marzouk M, et al. Viral infection risk in polytransfused adults: seroprevalence of seven viruses in central Tunisia. Bull Soc Pathol Exot 2011;104:220-5. [in French].
83. Konomi N, Miyoshi C, La Fuente Zerain C, et al. Epidemiology of hepatitis B, C, E, and G virus infections and molecular analysis of hepatitis G virus isolates in Bolivia. J Clin Microbiol 1999;37:3291-5.
84. Monteiro Tosoncin Da Silva S, Mendes De Oliveira J, Lamarca Vitra C, et al. Prevalence of hepatitis E virus antibodies in individuals exposed to swine in Mato Grosso, Brazil. Mem Inst Oswaldo Cruz 2012;107:338-41.
85. Bortoliero AL, Bonametti AM, Morimoto HK, et al. Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná, Brazil. Rev Inst Med Trop Sao Paulo 2006;48:87-92.
86. Trinta KS, Liberto MI, De Paula VS, et al. Hepatitis E virus infection in selected Brazilian populations. Mem Inst Oswaldo Cruz 2001;96:25-9.
87. Gonçales NS, Pinho JR, Moreira RC, et al. Hepatitis E virus immunoglobulin G antibodies in different populations in Campinas, Brazil. Clin Diagn Lab Immunol 2000;7:813-6.
88. Ibarra H, Riedemann S, Reinhardt G, et al. Prevalence of hepatitis E virus antibodies in blood donors and other population groups in southern Chile. Rev Med Chil 1997;125:275-8.
89. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries J Clin Microbiol 2002;40:117-22.
90. Mast EE, Kuramoto IK, Favorov MO, et al. Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California. J Infect Dis 1997;176:34-40.
91. Thomas DL, Yarbough PO, Vlahov D, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997;35:1244-7.
92. Cruells MR, Mescia G, Gaibisso R, et al. Epidemiological study of hepatitis A and E viruses in different populations in Uruguay. Gastroenterol Hepatol 1997;20:295-8.
93. Guo QS, Yan Q, Xiong JH, et al. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol 2010;48:317-8.
94. Cheng XF, Wen YF, Zhu M, et al. Serological and molecular study of hepatitis E virus among illegal blood donors. World J Gastroenterol 2012;18:986-90.
95. Guo QS, Yan Q, Xiong JH, et al. Prevalence of Hepatitis E Virus in Chinese Blood Donors. J Clin Microbiol 2010;48:317-8.
96. Taremi M, Gachkar L, Mahmoud Arabi S, et al. Prevalence of antibodies to hepatitis E virus among male blood donors in Tabriz, Islamic Republic of Iran. East Mediterr Health J 2007;13:98-102.
97. Assarehzadegana MA, Shakerinejad G, Aminib A, Rezaee SA. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, Southwest Iran. Intl J Infect Dis 2008;12:387-90.
98. Ehteram H, Ramezani A, Eslamifar A, et al. Seroprevalence of hepatitis E virus infection among volunteer blood donors in central province of Iran in 2012. Iran J Microbiol 2013;5:172-6.
99. Fukuda S, Ishikawa M, Ochiai N, et al. Unchanged high prevalence of antibodies to hepatitis E virus (HEV) and HEV RNA among blood donors with an elevated alanine aminotransferase level in Japan during 1991-2006. Arch Virol 2007;152:1623-35.
100. Takeda H, Matsubayashi K, Sakata H, et al. A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vo x Sang 2010;99:307-13.
101. Sakata H, Matsubayashi K, Takeda H, et al. A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase. Transfusion 2008;48:2568-76.
102. Gotanda Y, Iwata A, Ohnuma H, et al. Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan. J Med Virol 2007;79:734-42.
103. Irani Hakime N, Feghali Haibeh R. [Hepatitis E virus: detection of antibodies in blood donors in Lebanon.] J Med Liban 1998;46:60-2.
104. Seow HF, Mahomed NM, Mak JW, et al. Seroprevalence of antibodies to hepatitis E virus in the normal blood donor population and two aboriginal communities in Malaysia. J Med Virol 1999;59:164-8.
105. Johargy AK, Mahomed MF, Khan MM, Kabrah S. Antihepatitis E virus seropositivity in a group of male blood donors in Makkah, Saudi Arabia. J Pak Med Assoc 2013;63:185-9.
106. Abdelaal M, Zawawi TH, Al Sobhi E, et al. Epidemiology of hepatitis E virus in male blood donors in Jeddah, Saudi Arabia. Ir J Med Sci 1998;167:94-6.
107. Christensen PB, Engle RE, Hjort C, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008;47:1026-31.
108. Beale MA, Tettmar K, Szypulska R, et al. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang 2011;100:340-2.
109. Boutrouille A, Bakkali-Kassimi L, Crucière C, Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007;45:2009-10.
110. Corman VM, Drexler JF, Eckerle I, et al. Zoonotic hepatitis E virus strains in German blood donors. Vox Sang 2013;104:179-80.
111. Baylis SA, Nick S, Blümel J, Nübling CM. Hepatitis E virus and blood donors in Germany. Vox Sang 2010;98:479.
112. Vollmer T, Diekmann J, Johne R, et al. Novel Approach for Detection of Hepatitis E Virus Infection in German Blood Donors. J Clin Microbiol 2012;50:2708-13.
113. Juhl D, Baylis SA, Blümel J, and al. Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion 2013;54:49-56.
114. Krumbholz A, Mohn U, Lange J, et al. Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs. Med Microbiol Immunol 2012;201:239-44.
115. Dremsek P, Wenzel JJ, Johne R, et al. Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs. Med Microbiol Immunol 2012;201:189-200.
116. Dalekos GN, Zervou E, Elisaf M, et al. Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit. Transfusion 1998;38:589-95.
117. Pittaras T, Valsami S, Mavrouli M, et al. Seroprevalence of hepatitis E virus in blood donors in Greece. Vo x Sang 2014;106:387.
118. Scotto G, Giammario A, Centra M, et al. Seroprevalence of hepatitis E virus among blood donors in a district of Southern Italy. Blood Transfus 2012;10:565-6.
119. Masia G, Orrù G, Liciardi M, et al. Evidence of hepatitis E virus (HEV) infection in human and pigs in Sardinia, Italy. J Prev Med Hyg 2009;50:227-31.
120. Coppola RC, Masia G. Seroprevalence and epidemiological features of hepatitis E virus infection in Italy. In Rizzetto M, Purcell RH, Jerin J, Verme G, editors: Viral Hepatitis and Liver Disease. Minerva, Torino; 1997. p. 57-9.
121. Zanetti AR, Dawson GJ. Hepatitis type E in Italy: a seroepidemiological survey. Study Group of Hepatitis E. J Med Virol 1994;42:318-20.
122. Slot E, Hogema BM, Riezebos-Brilman A, et al. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013;18:pii=20550.
123. Macedo G, Pinto T, Sarmento JA, et al. The first assessment of hepatitis E virus seroprevalence in northern Portugal. Acta Med Port 1998;11:1065-8.
124. Queirós L, Condeço J, Tender A, et al. The seroprevalence for hepatitis E viral antibodies in the northern region of Portugal (among the donor population). Acta Med Port. 1997;10:447-53.
125. Cleland A, Smith L, Crossan C, et al. Hepatitis E virus in Scottish blood donors. Vo x Sang 2013;105:283-9.
126. Galiana C, Fernandez-Barredo S, Perez-Garcia MT. Prevalencia del virus de la hepatitis E (VHE) y factores de riesgo en trabajadores de explotaciones porcinas y donantes voluntarios. Enfermedades Infecciosas y Microbiología Clínica 2010;28:602-7.
127. Mateos ML, Camarero C, Lasa E, et al. Hepatitis E virus: relevance in blood donors and risk groups. Vo x Sang 1999;76:78-80.
128. Kaufmann A, Kenfak-Foguena A, André C, et al. Hepatitis E virus seroprevalence among blood donors in southwest Switzerland. PLoS One 2011;6:e21150.
129. Moaven L, Van Asten M, Crofts N, Locarnini SA. Seroepidemiology of hepatitis E in selected Australian populations. J Med Virol 1995;45:326-30.
130. Nelson P, Mathers B, Cowie B, et al. The epidemiology of viral hepatitis among people who inject drugs: results of global systematic reviews. Lancet 2011;378:571-83.
131. Dalton HR, Hunter JG, Bendall RP. Hepatitis E. Curr Opin Infect Dis 2013, 26:471-8.
132. Huang S, Zhang X, Jiang H, et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS One 2010;5:e13560.
133. Chandra NS, Sharma A, Malhotra B, Rai RR. Dynamics of HEV viremia, fecal shedding and its relationship with transaminases and antibody response in patients with sporadic acute hepatitis E. Virol J 2010;7:213.
134. Kamar N, Legrand-Abravanel F, Izopet J, Rostaing L. Hepatitis E virus: what transplant physicians should know. Am J Transplant 2012;12:2281-7.
135. Drobeniuc J, Meng J, Reuter G, et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010;51:e24-7.
136. Bendall R, Ellis V, Ijaz S, et al. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010;82:799-805.
137. Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009;361:1025-7.
138. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010;139:1612-8.
139. Baylis SA, Hanschmann KM, Blümel J, and the HEV Collaborative Study Group. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011;49:1234-9.
140. AABB. Hepatitis E virus updated February 2014. Update to Transfusion 2009;49(Suppl):93-95S. Available at: http://www.aabb.org/resources/bct/eid/Documents/hepatitis-E-virus.pdf. Accessed on 21/05/2014.
141. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology 2012;142:1388-97.
142. Davern TJ, Chalasami N, Fontana RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011;41:1665-72.
143. González Tallón AI, Moreira Vicente V, Mateos-Lindemann ML, et al. Chronic hepatitis E in an immunocompetent patient. Gastroenterología y Hepatología 2011;34:398-400. [in Spanish].
144. De Niet A, Zaaijer HL, Ten Berge I, et al. Chronic hepatitis E after solid organ transplantation. Neth J Med. 2012;70:261-6.
145. Abravanel F, Mansuy JM, Huynh A, et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 2012;54:152-5.
146. Kamar N, Izopet J, Rostaing L. No reactivation of hepatitis E virus after kidney retransplantation. Am J Transplant 2012;12:507-8.
147. Shukla P, Nguyen HT, Torian U, et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci USA 2011;108:2438-43.
148. Sood A, Midha V, Sood N. Guillain-Barré syndrome with acute hepatitis E. Am J Gastroenterol 2000;95:3667-8.
149. Dixit VK, Abhilash VB, Kate MP, Jain AK. Hepatitis E infection with Bell's palsy. J Assoc Physicians India 2006;54:418.
150. Fong F, Illahi M. Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg 2009;111:193-5.
151. Kejariwal D, Roy S, Sarkar N. Seizure associated with acute hepatitis E. Neurology 2001;57:1935.
152. Kamar N, Bendall RP, Peron JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011;17:173-9.
153. Deniel C, Coton T, Brardjanian S, et al. Acute pancreatitis: a rare complication of acute hepatitis E. J Clin Virol 2011;51:202-4.
154. Al-Shukri I, Davidson E, Tan A, et al. Rash and arthralgia caused by hepatitis E. Lancet 2013;382:1856.
155. Singh NK, Gangappa M. Acute immune thrombocytopenia associated with hepatitis E in an adult. Am J Hematol 2007;82:942-3.
156. Ali G, Kumar M, Bali SK, et al. Hepatitis E associated immune thrombocytopenia and membranous glomerulonephritis. Indian J Nephrol 2001;11:70-2.
157. Thapa R, Mallick D, Biswas B. Henoch Schonlein purpura triggered by acute hepatitis E virus infection. J Emerg Med 2010;39:218-9.
158. Gerolami R, Borentain P, Raissouni F, et al. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011;52:60-2.
159. Debing Y, Neyts J. Antiviral strategies for hepatitis E virus. Antiviral Research 2014;102:106-118.
160. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356:895-903.
161. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a largescale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010;376:895-902.
162. Pas SD, Streefkerk RH, Pronk M, et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 2013;58:629-34.
163. Wu WC, Su CW, Yang JY, et al. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area. J Med Virol 2014;86:720-8.
164. Féray C, Pawlotsky JM, Roque-Afonso AM, et al. Should we screen blood products for hepatitis E virus RNA? Lancet 2014;383:218.
165. Dreier J, Juhl D. Autochthonous hepatitis E virus infections: a new transfusion-associated risk? Transfus Med Hemother 2014;41:29-39.
166. Kleinman SH, Glynn SA, Higgins MJ, et al. The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Transfusion 2005;45:1073-83.
167. Benjamin RJ. The RADAR repository: providing a prospective perspective on the past. Transfusion 2005;45:1051-3.